ERBB2 and breast cancer: Although HER2 expression was initially associated with breast cancer it has now been implicated in various cancers including, colon, bladder, ovary, uterine cervix, gastric and GEJ cancers (Reicheelt et al., 2007; Kaur et al., 2011).